Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation
about
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation
description
scientific article published on 01 February 2020
@en
name
Changes in Airway Microbiome a ...... ibrosis and the G551D Mutation
@en
type
label
Changes in Airway Microbiome a ...... ibrosis and the G551D Mutation
@en
prefLabel
Changes in Airway Microbiome a ...... ibrosis and the G551D Mutation
@en
P50
P1476
Changes in Airway Microbiome a ...... ibrosis and the G551D Mutation
@en
P2093
Mark J Stevens
P304
P356
10.1513/ANNALSATS.201907-493OC
P50
P577
2020-02-01T00:00:00Z